Wellness Peptides Are Going Mainstream. The Science Hasn’t Kept Up

A physician examines whether the FDA's loosening of wellness peptide restrictions means these compounds are actually safe and ...

Kura Oncology Reports Darlifarnib Plus Cabozantinib Demonstrates Robust Activity in Patients With Clear Cell Renal Cell Carcinoma Previously Treated With Cabozantinib

Data from subset analysis of cabozantinib-pretreated patients support potential to overcome resistance and resensitize tumors to VEGF TKI ...